Ghasemi Mehdi, Sadeghipour Hamed, Mani Ali R, Tavakoli Sina, Hajrasouliha Amir Reza, Ebrahimi Farzad, Dehpour Ahmad Reza
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
Eur J Pharmacol. 2006 Aug 21;544(1-3):138-45. doi: 10.1016/j.ejphar.2006.06.002. Epub 2006 Jun 14.
The purpose of this study was to investigate the effect of the endogenous cannabinoid anandamide on the nonadrenergic noncholinergic (NANC) relaxant responses to electrical field stimulation in isolated rat corpus cavernosum. The corporal strips were mounted under tension in a standard oxygenated organ bath with guanethidine sulfate (5 microM) and atropine (1 microM) (to produce adrenergic and cholinergic blockade). The strips were precontracted with phenylephrine hydrochloride (7.5 microM) and electrical field stimulation was applied at different frequencies to obtain NANC-mediated relaxation. The expression of CB1, CB2 and vanilloid receptor proteins within the rat corpus cavernosum was evaluated using western blot analysis. The results showed that the relaxant responses to electrical stimulation were significantly enhanced in the presence of anandamide at 1 and 3 microM. The potentiating effect of anandamide (1 microM) on relaxation responses was significantly attenuated by either the selective cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251; 1 microM) or the vanilloid receptor antagonist capsazepine (3 microM), but not by the selective cannabinoid CB2 receptor antagonist 6-iodo-2-methyl-1-[2-(4-morpholinyl) ethyl]-1H-indol-3-yl (4-methoxyphenyl)methanone (AM630; 1 microM). Neither of these antagonists had influence on relaxation responses. Indomethacin (20 microM) had no effect on NANC-mediated relaxation in the presence or absence of anandamide (1 microM). Preincubation with Nw-Nitro-L-Arginine Methyl Ester (L-NAME; 1 microM) significantly inhibited the relaxation responses in the presence or absence of 1 microM anandamide. Although at 30 nM, L-NAME did not cause a significant inhibition of relaxant responses individually, it significantly inhibited the potentiating effect of anandamide (1 microM) on relaxation responses. Anandamide (1 microM) had no influence on concentration-dependent relaxant responses to sodium nitroprusside (10 nM-1 mM), a nitric oxide (NO) donor. The western blotting of corporal tissues demonstrated the existence of both vanilloid and CB1 receptors in corporal strips. In conclusion, our results showed that anandamide has a potentiating effect on NANC-mediated relaxation of rat corpus cavernosum through both CB1 and vanilloid receptors and the NO-mediated component of the NANC relaxant responses to electrical stimulation is involved in this enhancement.
本研究旨在探讨内源性大麻素花生四烯酸乙醇胺对离体大鼠海绵体电场刺激引起的非肾上腺素能非胆碱能(NANC)舒张反应的影响。将海绵体条带置于含硫酸胍乙啶(5微摩尔)和阿托品(1微摩尔)(以产生肾上腺素能和胆碱能阻断)的标准充氧器官浴中,使其处于张力状态。用盐酸去氧肾上腺素(7.5微摩尔)使条带预收缩,然后以不同频率施加电场刺激以获得NANC介导的舒张。采用蛋白质印迹分析评估大鼠海绵体内CB1、CB2和香草酸受体蛋白的表达。结果显示,在存在1微摩尔和3微摩尔花生四烯酸乙醇胺的情况下,对电刺激的舒张反应显著增强。花生四烯酸乙醇胺(1微摩尔)对舒张反应的增强作用被选择性大麻素CB1受体拮抗剂N-(哌啶-1-基)-5-(4-碘苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(AM251;1微摩尔)或香草酸受体拮抗剂辣椒素(3微摩尔)显著减弱,但未被选择性大麻素CB2受体拮抗剂6-碘-2-甲基-1-[2-(4-吗啉基)乙基]-1H-吲哚-3-基(4-甲氧基苯基)甲酮(AM630;1微摩尔)减弱。这些拮抗剂均未对舒张反应产生影响。吲哚美辛(20微摩尔)在存在或不存在花生四烯酸乙醇胺(1微摩尔)的情况下,对NANC介导的舒张均无影响。用Nω-硝基-L-精氨酸甲酯(L-NAME;1微摩尔)预孵育在存在或不存在1微摩尔花生四烯酸乙醇胺的情况下均显著抑制舒张反应。虽然在30纳摩尔时,L-NAME单独不会引起舒张反应的显著抑制,但它显著抑制了花生四烯酸乙醇胺(1微摩尔)对舒张反应的增强作用。花生四烯酸乙醇胺(1微摩尔)对一氧化氮(NO)供体硝普钠(10纳摩尔 - 1毫摩尔)的浓度依赖性舒张反应没有影响。海绵体组织的蛋白质印迹显示海绵体条带中同时存在香草酸受体和CB1受体。总之,我们的结果表明,花生四烯酸乙醇胺通过CB1受体和香草酸受体对大鼠海绵体NANC介导的舒张具有增强作用,并且电刺激引起的NANC舒张反应中由NO介导的部分参与了这种增强作用。